CollPlant Biotechnologies... (CLGN)
NASDAQ: CLGN
· Real-Time Price · USD
2.50
-0.11 (-4.21%)
At close: Aug 15, 2025, 3:57 PM
2.48
-0.80%
After-hours: Aug 15, 2025, 04:10 PM EDT
-4.21% (1D)
| Bid | 2.2 |
| Market Cap | 28.64M |
| Revenue (ttm) | 2.47M |
| Net Income (ttm) | -13.87M |
| EPS (ttm) | -1.21 |
| PE Ratio (ttm) | -2.07 |
| Forward PE | 286 |
| Analyst | Buy |
| Ask | 3.18 |
| Volume | 14,225 |
| Avg. Volume (20D) | 125,674 |
| Open | 2.54 |
| Previous Close | 2.61 |
| Day's Range | 2.48 - 2.54 |
| 52-Week Range | 1.31 - 5.45 |
| Beta | 0.78 |
About CLGN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLGN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
CollPlant Biotechnologies Ltd. is scheduled to release its earnings on
Aug 20, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+15.28%
CollPlant Biotechnologies shares are trading highe...
Unlock content with
Pro Subscription
2 months ago
-29.96%
CollPlant Biotechnologies shares are trading lower after the company announced a $3.6 million capital raise through a registered direct offering.
4 months ago · seekingalpha.com
CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call TranscriptCollPlant Biotechnologies Ltd. (NASDAQ:CLGN ) Q4 2024 Earnings Conference Call March 26, 2025 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO...